RGLS

Regulus Therapeutics

Delisted

RGLS was delisted on the 24th of June, 2025.

68 hedge funds and large institutions have $52.9M invested in Regulus Therapeutics in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

65% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 23

83% less call options, than puts

Call options by funds: $52K | Put options by funds: $301K

Holders
68
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$52K
Puts
$301K
Net Calls
Net Calls Change

Top Buyers

1 +$743K
2 +$542K
3 +$378K
4
Morgan Stanley
Morgan Stanley
New York
+$215K
5
ARTA
A.R.T. Advisors
New York
+$163K

Top Sellers

1 -$1.47M
2 -$1.39M
3 -$1.26M
4
NI
Numeric Investors
Massachusetts
-$1.08M
5
A
Abingworth
United Kingdom
-$1.08M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$197K
27
$180K
28
$175K
29
$163K
30
$148K
31
$140K
32
$139K
33
$106K
34
$105K
35
$103K
36
$89K
37
$88K
38
$78K
39
$70K
40
$66K
41
$64K
42
$58K
43
$56K
44
$55K
45
$54K
46
$50K
47
$46K
48
$45K
49
$41K
50
$39K